[go: up one dir, main page]

AR056268A1 - Tabletas que comprenden una sustancia biologicamente activa y un excipiente - Google Patents

Tabletas que comprenden una sustancia biologicamente activa y un excipiente

Info

Publication number
AR056268A1
AR056268A1 ARP060100565A ARP060100565A AR056268A1 AR 056268 A1 AR056268 A1 AR 056268A1 AR P060100565 A ARP060100565 A AR P060100565A AR P060100565 A ARP060100565 A AR P060100565A AR 056268 A1 AR056268 A1 AR 056268A1
Authority
AR
Argentina
Prior art keywords
biologically active
excipient
active substance
tablets
calcium carbonate
Prior art date
Application number
ARP060100565A
Other languages
English (en)
Inventor
Karine Cavalier
Didier Sy
Roberto Rosa
Bernard Bataille
Michele Delalonde
Gilles Baylac
Alberto Galasco
Original Assignee
Solvay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay filed Critical Solvay
Publication of AR056268A1 publication Critical patent/AR056268A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

Tableta que comprende al menos una sustancia biologicamente activa y un excipiente, en la cual el excipiente contiene carbonato de calcio al menos un aditivo que se selecciona entre ácidos grasos, sus sales, sus ésteres, materiales lipídicos, polisacáridos, polivinilpirrolidona y derivados de polivinilpirrolidona, compuestos acrílicos, mono, di o triglicéridos, proteínas animales, y mezclas de al menos dos de ellos. Método para producir estas tabletas. Uso de carbonato de calcio en tabletas que contienen al menos una sustancia biologicamente activa, para la liberacion prolongada de esta sustancia.
ARP060100565A 2005-02-16 2006-02-16 Tabletas que comprenden una sustancia biologicamente activa y un excipiente AR056268A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0501580A FR2881957B1 (fr) 2005-02-16 2005-02-16 Comprimes comprenant une substance biologiquement active et un excipient

Publications (1)

Publication Number Publication Date
AR056268A1 true AR056268A1 (es) 2007-10-03

Family

ID=35045407

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060100565A AR056268A1 (es) 2005-02-16 2006-02-16 Tabletas que comprenden una sustancia biologicamente activa y un excipiente

Country Status (7)

Country Link
US (1) US7892576B2 (es)
EP (1) EP1853236A1 (es)
JP (1) JP2008530175A (es)
AR (1) AR056268A1 (es)
FR (1) FR2881957B1 (es)
TW (1) TW200640442A (es)
WO (1) WO2006087312A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2876999B1 (fr) * 2004-10-25 2007-11-09 Solvay Suspensions contenant des particules de carbonate de calcium presentant un etat d'agregation controle
EP1657278A1 (en) 2004-11-12 2006-05-17 SOLVAY (Société Anonyme) Coated particles of calcium carbonate having a high specific surface
KR20150113210A (ko) 2004-12-22 2015-10-07 솔베이(소시에떼아노님) 알칼리 토금속 카르보네이트의 내산성 입자
EP1746073A1 (en) * 2005-07-20 2007-01-24 SOLVAY (Société Anonyme) Process for making a solid compound by precipitation, suspensions of solid in liquids and solids obtained by the process and their use as additives
WO2010093285A1 (en) * 2009-02-12 2010-08-19 Aduro Material Ab Composition comprising biodegradable carrier for controlled drug delivery
KR20120003906A (ko) * 2009-03-27 2012-01-11 교린 세이야꾸 가부시키 가이샤 염기성 첨가제를 함유하는 매트릭스형 서방성 제제
CA2758618C (en) * 2009-04-24 2017-03-28 Omya Development Ag Particulate material for controlled release of active ingredients
JP2011057586A (ja) * 2009-09-08 2011-03-24 Kyorin Pharmaceutical Co Ltd ｐＨ非依存性マトリックス型徐放性製剤
PL2719376T3 (pl) * 2012-10-12 2015-08-31 Omya Int Ag Gastroretencyjny preparat leku oraz sposoby dostarczania i sposób jego wytwarzania z użyciem funkcjonalizowanego węglanu wapnia
EP3034070A1 (en) * 2014-12-18 2016-06-22 Omya International AG Method for the production of a pharmaceutical delivery system
EP3069713A1 (en) 2015-03-20 2016-09-21 Omya International AG Dispersible dosage form
EP3176222A1 (en) * 2015-12-01 2017-06-07 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789938A (en) * 1952-11-24 1957-04-23 Merck & Co Inc Method of producing a diuretic effect with p-carboxybenzenesulfonamide
US3475419A (en) * 1967-12-06 1969-10-28 Sterling Drug Inc 17 - hydroxy - 3 - oxyestra - 1,3,5(10) - triene-17alpha-carboxaldehydes and derivatives
US3597420A (en) * 1969-02-17 1971-08-03 Sterling Drug Inc Tertiary-amino-lower-alkoxy-9-benzylidene-xanthenes and thioxanthenes
ZA761305B (en) * 1975-03-17 1977-02-23 Hoffmann La Roche Sustained release formulation
US4744987A (en) * 1985-03-08 1988-05-17 Fmc Corporation Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
JPS62277322A (ja) * 1986-02-13 1987-12-02 Takeda Chem Ind Ltd 安定化された腸溶性抗潰瘍固形組成物
CA1327010C (en) * 1986-02-13 1994-02-15 Tadashi Makino Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
US5433959A (en) * 1986-02-13 1995-07-18 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
JPH0798742B2 (ja) * 1986-07-03 1995-10-25 ゼリア新薬工業株式会社 徐放性製剤組成物
US4755987A (en) * 1987-06-05 1988-07-05 Bell Communications Research, Inc. High speed scrambling at lower clock speeds
JP2538134B2 (ja) * 1991-04-08 1996-09-25 田辺製薬株式会社 徐放性製剤およびその製造法
CA2067975C (en) * 1991-05-20 2003-01-14 Cynthia M. Blase Buffered matrix aspirin tablet
JP2525975B2 (ja) * 1991-09-06 1996-08-21 備北粉化工業株式会社 低分子量キトサン含有植物機能調節用組成物
US5741471A (en) * 1995-12-05 1998-04-21 Minerals Technologies Inc. Process for the preparation of discrete particles of calcium carbonate
GB9600390D0 (en) 1996-01-09 1996-03-13 Univ London Pharmacy Preparation of tablets
WO1998002185A1 (en) * 1996-07-12 1998-01-22 Daiichi Pharmaceutical Co., Ltd. Quickly disintegrable compression-molded materials and process for producing the same
US20030161894A1 (en) * 2001-09-05 2003-08-28 3P Technologies Ltd. Precipitated aragonite and a process for producing it
JP2002348234A (ja) 2001-05-28 2002-12-04 Purotekku:Kk 薬物封入無機物微粒子、その製造法及び薬物封入無機物微粒子製剤
FR2826950B1 (fr) * 2001-07-04 2004-09-10 Solvay Procede pour l'obtention de particules de carbonate de calcium precipite structurees a l'echelle nanometrique
FR2862308B1 (fr) * 2003-11-14 2008-02-15 Solvay Procede de fabrication d'une resine synthetique et resine synthetique obtenue au moyen de ce procede
FR2876999B1 (fr) 2004-10-25 2007-11-09 Solvay Suspensions contenant des particules de carbonate de calcium presentant un etat d'agregation controle
EP1657278A1 (en) 2004-11-12 2006-05-17 SOLVAY (Société Anonyme) Coated particles of calcium carbonate having a high specific surface
KR20150113210A (ko) 2004-12-22 2015-10-07 솔베이(소시에떼아노님) 알칼리 토금속 카르보네이트의 내산성 입자
EP1893546B1 (en) 2005-06-15 2019-12-25 Imertech Sas Use of particles of calcium carbonate in the production of construction materials
EP1746073A1 (en) 2005-07-20 2007-01-24 SOLVAY (Société Anonyme) Process for making a solid compound by precipitation, suspensions of solid in liquids and solids obtained by the process and their use as additives
ITMI20051464A1 (it) 2005-07-28 2007-01-29 Macri Chemicals Srl Composizioni di vernici e loro impiego per il rivestimento di superfici di substrati
FR2891546B1 (fr) 2005-10-04 2010-09-03 Solvay Utilisation de particules de carbonate de calcium dans des compositions polymeriques transparentes, compositions polymeriques transparentes et procede de fabrication de ces compositions

Also Published As

Publication number Publication date
TW200640442A (en) 2006-12-01
EP1853236A1 (en) 2007-11-14
US20080131506A1 (en) 2008-06-05
US7892576B2 (en) 2011-02-22
FR2881957A1 (fr) 2006-08-18
FR2881957B1 (fr) 2008-08-08
WO2006087312A1 (en) 2006-08-24
JP2008530175A (ja) 2008-08-07

Similar Documents

Publication Publication Date Title
ES2524320T3 (es) Composición para la prevención o el tratamiento de enfermedad asociada con trombo o émbolo
AR056268A1 (es) Tabletas que comprenden una sustancia biologicamente activa y un excipiente
CY1108700T1 (el) Συνθεσεις απελευθερωσης φαρμακου εστερα αλφα-υδροξυ οξεος και μεθοδοι χρησης
WO2005079853A3 (en) Soft gelatin capsule comprising omega-3 polyunsaturated fatty acid
CL2009000967A1 (es) Compuesto 4-ciclobutil-n-((2s,5r)-5-hidroxi-2-adamantil)-2-morfolin-4-ilpiridin-5-carboxamida, inhibidor de la enzima 11betahsd1; composicion farmaceutica que lo comprende; y su uso en un procedimiento de tratamiento profilactico o terapeutico de un animal de sangre caliente.
ECSP077999A (es) Formulaciones de una sal de bupropion de liberación modificada
ECSP077836A (es) Compuestos mejorados farmacocinéticamente
EA200701913A1 (ru) Лечение статином, омега-3 жирными кислотами и их комбинированным продуктом
ECSP088461A (es) Composiciones farmacéuticas que contienen buprenorfina
DK2436275T3 (da) Lipidsammensætning til forbedring af hjernefunktion
UY31867A (es) Nuevas formulaciones farmacéuticas sólidas que comprenden bibw 2992
UY29853A1 (es) Derivados de diacilindazol como inhibidores de lipasas y fosfolipasas-
UY28468A1 (es) Tableta que contiene el éster etílico de ácido 3-((2-((4-(hexiloxicarbonilamino-imino-metil)-fenilamino)-metil)-1-metil-1h-bencimidazol-5-carbonil)-piridin-2-il-amino)-propiónico o sus sales.
CL2008000661A1 (es) Composiciones de sales bajas en sodio, metodos de preparacion, y uso de las mismas.
AR060264A1 (es) Composicion farmaceutica que contiene lactato y calcio, usos de dicha composicion y metodo de preparacion
HN2006035237A (es) Derivados de triazolopiridina en calidad de inhibidores de lipasas y fosfolipasas
ES2531516T3 (es) Uso de escina
DOP2006000168A (es) Dispositivos transdérmicos de liberación de fármaco que contienen drospirenona y métodos de liberación de los mismos
ECSP10010576A (es) Formulaciones orales e inyectables de compuestos de tetraciclina
RU2009128593A (ru) Средства борьбы с паразитами животных
PE20050923A1 (es) Composicion solida que comprende un sensibilizador de insulina, un secretagogo de insulina y un ester de acidos grasos
GT200600463A (es) Derivados de carbamoilbenzotriazol como inhibidores de lipasas y fosfolipasas
ES2581331T3 (es) Inhibidor de la progresión de una enfermedad atribuida a una acumulación anormal de grasa hepática
DK1820506T3 (da) Dipyridamol-formuleringer med forlænget frigivelse og fremgangsmåde til fremstilling heraf
ES2531599T3 (es) Utilización de triglicéridos docosahexaenoicos para el tratamiento de enfermedades tumorales

Legal Events

Date Code Title Description
FB Suspension of granting procedure